Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical immunity to malaria.

Louis Schofield1, Ivo Mueller

  • 1The Walter and Eliza Hall Institute of Medical Research, 1G, Royal Parade, Parkville, Victoria 3050, Australia. schofield@wehi.edu.au

Current Molecular Medicine
|March 7, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal serological detection of exposure to SARS-CoV-2 in a cohort of pregnant women in Malawi: a secondary analysis from a randomised controlled trial.

BMJ open·2026
Same author

Assessing the effect of parasite antigen genetic diversity on performance of Plasmodium vivax serological exposure markers for malaria: a multicentre observational diagnostic accuracy study.

The Lancet. Microbe·2026
Same author

Understanding <i>Plasmodium vivax</i> recurrent infections using an amplicon deep sequencing assay, identity-by-descent and model-based classification.

iScience·2026
Same author

PvDBP gene amplification is associated with functional immune evasion by Plasmodium vivax in vivo.

Research square·2026
Same author

Divergent inflammatory and neurology-related protein levels in long COVID following primary and breakthrough SARS-CoV-2 infections.

Communications medicine·2026
Same author

Predicting Risk of Plasmodium Vivax Microscopy-Detected Episodes Using Serological Markers in Patients With Plasmodium falciparum Malaria: A Multicountry Diagnostic Performance Evaluation.

The Journal of infectious diseases·2026
Same journal

Corrigendum to: Sortilin as a Culprit in the Atherosclerosis Plaque Progression: Evidence from Clinical and Experimental Studies.

Current molecular medicine·2026
Same journal

Dynamic Expression of Fibroblast Activation Protein (FAP) During Chronic Pancreatitis (CP) Progression in Mice and Evaluation of FAP-targeted Tracers for Early CP Diagnosis.

Current molecular medicine·2026
Same journal

Causal Relationship Between 91 Inflammatory Factors and Gastritis: A Two-Sample Bidirectional Mendelian Randomization Study.

Current molecular medicine·2026
Same journal

Therapeutic Potential of Pistacia Atlantica Gum in Aspirin-Induced Peptic Ulcers: A Dose-Dependent Approach to Mucosal Protection and Hepatorenal Safety.

Current molecular medicine·2026
Same journal

Identification and Characterization of MicroRNAs Associated with Borax-mediated Anti-tumor Activity through High-throughput Technology.

Current molecular medicine·2026
Same journal

Broad-Spectrum Vaccines: Challenges and Opportunities (A Systematic Review).

Current molecular medicine·2026
See all related articles

Functional immunity to malaria develops in stages, first protecting against severe disease, then mild cases, and finally reducing parasite load. This suggests clinical immunity is distinct from anti-parasite immunity, crucial for vaccine development.

Area of Science:

  • Immunology
  • Tropical Medicine
  • Vaccinology

Background:

  • Malaria functional immunity acquisition occurs in distinct stages.
  • Clinical immunity to severe disease and mild malaria is acquired earlier than anti-parasite immunity.
  • Current malaria vaccine strategies primarily target anti-parasite immunity, not clinical immunity.

Purpose of the Study:

  • To review the targets and determinants of clinical immunity to malaria.
  • To explore the distinct stages of functional immunity acquisition.
  • To discuss implications for malaria vaccine development.

Main Methods:

  • Literature review of studies on malaria immunity.
  • Analysis of distinct stages of functional immunity.
  • Examination of candidate mechanisms for clinical immunity.

Related Experiment Videos

Main Results:

  • Functional immunity develops in three stages: protection against severe disease, then mild malaria, and finally partial reduction of pathogen burden.
  • Clinical immunity is acquired more easily and earlier than anti-parasite immunity.
  • Candidate mechanisms for clinical immunity include immunity to cytoadherence, toxin tolerance, acquired immunity to toxins, and immunoregulation.

Conclusions:

  • Clinical immunity and anti-parasite immunity are distinct processes with different acquisition timelines and efficacies.
  • Achieving clinical immunity is the public health objective for malaria control.
  • Understanding the mechanisms of clinical immunity is vital for developing effective malaria vaccines.